This process yielded a proposed three-protein panel consisting of pro-platelet basic protein (PPBP, also known as CXCL7), enolase 1 (ENO1), and beta-2-glycoprotein 1 (APOH), which were significantly elevated in AML patients’ samples compared to controls [22]. This evidence concerns the gene ENO1 and acute myeloid leukemia.